Journal of the National Cancer Institute Advance Access originally published online on June 9, 2009
JNCI Journal of the National Cancer Institute 2009 101(12):837-838; doi:10.1093/jnci/djp138
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press.
EDITORIALS |
Quality Pancreatic Cancer Care: It's Still Mostly About Volume
Affiliation of author: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
Correspondence to: Murray F. Brennan, MD, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (e-mail: brennanm@mskcc.org).
| The first 10% of the full text of this article appears below. |
Even the most optimistic of oncologists must view with dismay the minimal improvement in overall survival for pancreatic adenocarcinoma. Progress has been made in diagnosis, selection of patients for operation, and resection, with markedly decreased mortality but persistent morbidity following operation and minimal survival improvement with adjuvant chemotherapy. These improvements have had secondary benefits for patients who are suspected of having pancreatic adenocarcinoma but who prove to have less lethal histological diagnoses and improved survival following resection.
In this issue of the Journal, Bilimoria et al. (1) identify a series
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2009 101: 835.
J Natl Cancer Inst 2009 101: 835.